Back to Feed
ClinicalTrials.gov|Clinical Trial
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
Peking University First Hospital
Abstract
This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus. Phase: NA Status: NOT_YET_RECRUITING Conditions: Diabetes Mellitus Interventions: iPSC-derived islet cell
Keywords
Diabetes Mellitus